Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.36 |
| ▸ | PDE5A | O76074 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1263256 | 0.96 | CYP1B1 (0.50) | CYP1B1KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL17514405 | 0.88 | KMT2A (0.48) | CYP1B1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL17514393 | 0.84 | KMT2A (0.49) | CYP1B1ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL5130178 | 0.82 | CA12 (0.38) | CYP1B1KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL14302830 | 0.82 | CYP1B1 (0.63) | CYP1B1KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL19245351 | 0.80 | TERT (0.41) | CYP1B1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL1513164 | 0.78 | CA12 (0.39) | CYP1B1KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL1264014 | 0.77 | NPSR1 (0.36) | CYP1B1ALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL19245352 | 0.76 | TERT (0.39) | CYP1B1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL1264036 | 0.74 | STAT3 (0.46) | KDM4EALDH1A1MEN1KMT2ATERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | claimed |
| EP-2104676-A2 | METHODS FOR PREPARING ARENE-BIS(DICARBOXIMIDE)-BASED SEMICONDUCTING MATERIALS AND RELATED INTERMEDIATES FOR PREPARING SAME | Polyera Corporation (US) | 2009-09-30 | — | — | EP | claimed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | claimed |
| WO-2008085942-A2 | METHODS FOR PREPARING ARENE-BIS(DICARBOXIMIDE)-BASED SEMICONDUCTING MATERIALS AND RELATED INTERMEDIATES FOR PREPARING SAME | POLYERA CORPORATION (US) | 2008-07-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | RECQL, CCNE2, CCNE1 | CYP1B1 1142/4885KDM4E 1028/4885ALDH1A1 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.